CRL vs RVTY · rev $2.00B vs P/E 42, rev $1.44B
Charles River Laboratories (CRL) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
CRL currently screens at market cap $7.78B. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the CRL and RVTY stock pages for the full models.
Not investment advice.